Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
550.4 INR | +2.58% | +2.62% | +66.62% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
Sales 2022 | 11.47B 137M | Sales 2023 | 10.52B 126M | Capitalization | 19.91B 239M |
---|---|---|---|---|---|
Net income 2022 | 607M 7.27M | Net income 2023 | -325M -3.89M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 78.84M | Net Debt 2023 | 7.79B 93.36M | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | 1,179 |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 39.28% |
Latest transcript on Shilpa Medicare Limited
1 day | +2.58% | ||
1 week | +2.62% | ||
Current month | +19.50% | ||
1 month | +19.50% | ||
3 months | +71.98% | ||
6 months | +62.39% | ||
Current year | +66.62% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 21-05-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Director/Board Member | 58 | 21-09-01 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 21-09-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 550.4 | +2.58% | 596,856 |
24-04-29 | 536.5 | -1.39% | 448,201 |
24-04-26 | 544 | +2.48% | 374,684 |
24-04-25 | 530.9 | -0.04% | 123,694 |
24-04-24 | 531.1 | -0.73% | 241,892 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.00% | 704B | |
+25.88% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+15.19% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- SHILPAMED Stock
- SHILPAMED Stock